Abstract
Abstract Background Management of Cardiovascular Disease (CVD) risk is dependent on Low Density Lipoprotein Cholesterol (LDL-C) levels; therefore LDL-C serves as the marker for the assessment of CVD risk and the focus of lipid lowering treatment. The gold standard reference method for measurement of LDL-C is beta-quantification. We compared calculated LDL-C with Friedewald (F-LDL-C), Martin-Hopkins (M-LDL-C) and Sampson (S-LDL-C) equations versus LDL-C directly measured (D-LDL-C). In CVD management also cholesterol ratios are evaluated. TC/HDL is associated with morbidity and mortality in the general population. Furthermore, several studies have stated that high triglycerides (TG) levels and low HDL-C (TG/HDL ratio) could function as an atherogenic index. Methods 11399 samples were analyzed on Siemens Atellica Solution® for the lipid profile determination measuring Total Cholesterol (TC), D-LDL-C, HDL-C and TG. In the absence of additional clinical parameters, based on desirable levels for LDL-C recommended by guidelines, CVD risk was evaluated by assigning to LDL-C a cut-off of 100 mg/dL. In presence of misclassifications, we used two other parameters to assess LDL-C results: TG/HDL-C ratio and CT/HDL-C. Results Patients cohort had a mean age of 57.7 (±16.8) years of which 53% (age=58.6, ±15.9) were males and 47% (age=56.5, ±17.8 years) were females. Of these, the 57.7% were outpatients and 42.3% inpatients (42.1% of infectious diseases - 24.4% of the cardiovascular department). Data about LDL-C misclassification and ratio data parameters are shown in table 1. Discordant patients for D-LDL-C vs F-LDL-C are 8.5%, that of D-LDL-C vs M-LDL-C are 7.7% and D-LDL-C vs S-LDL-C are 7.2%. Conclusions Is known that LDL plays a central role in the pathogenesis of atherosclerosis. Accurate estimation of LDL-C is a fundamental point for the stratification of CVD risk and the achievement of the therapeutic goal; however, we are still uncertain about the best and accurate way to measure it.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
